Stifel Financial
BCYC

Stifel Financial’s Bicycle Therapeutics BCYC Stock Holding History

Stifel Financial’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.1K Buy
+14,687
New +$83.9K ﹤0.01% 3563
2022
Q2 		– Sell
-31,746
Closed -$1.39M – 3330
2022
Q1 		$1.39M Sell
31,746
-3,213
-9% -$150K ﹤0.01% 1885
2021
Q4 		$2.13M Sell
34,959
-2,928
-8% -$162K ﹤0.01% 1574
2021
Q3 		$1.58M Sell
37,887
-4,251
-10% -$149K ﹤0.01% 1739
2021
Q2 		$1.28M Buy
+42,138
New +$1.27M ﹤0.01% 1911

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stifel Financial's BCYC Position: Q1 2026 in Review

Stifel Financial opened a new position in Bicycle Therapeutics (BCYC) in Q1 2026: 14,687 shares worth $68.1K. The stake represents ﹤0.01% of the portfolio and ranks #3563 among its holdings. This is a return to the name: Stifel Financial previously reported a position in BCYC as recently as Q1 2022.

Stifel Financial first reported a position in BCYC in Q2 2021 and has held it in 5 quarters since. The position peaked at $2.13M in Q4 2021. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Stifel Financial held 14,687 shares of Bicycle Therapeutics worth $68.1K as of Q1 2026.
  • Bicycle Therapeutics was a new Stifel Financial position in Q1 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3563 holding.
  • Stifel Financial first reported a position in Bicycle Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • Stifel Financial's Bicycle Therapeutics position peaked at $2.13M in Q4 2021.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.